ChartRow logo
ChartRow
Investing Charts
BIIB
Biogen Inc.Stock · HealthcareS&P 500 0.0%
$202.19+$1.57 (+0.78%)as of market close, Jul 24, 2026
CompareLLYUNHJNJABBVISRGABT

BIIBBiogen Inc. stock price, chart and key statistics

Key stats

Price data

Price
$202.19
Change YTD
+13.70%
Next earnings
Jul 29, 2026 · Before open
Market cap
29.9B
Enterprise value
32.8B
Shares outstanding
147.6M
52W low
$124.56
52W high
$219.72
From 52W high
-7.98%
From 52W low
+62.32%
52W range
82%
Beta
0.16

Volume

Rel volume
0.61×
30D volume
1.4M
30D $ vol
274M

Fundamentals

Sales (ttm)
9.9B
Sales/share
$67.31
EPS (ttm)
$9.24
FCF (ttm)
2.4B
FCF/share
$16.41
Book value/share
$126.33
Net margin
13.81%
ROE
7.36%
ROA
4.65%
Debt / equity
0.34×
Current ratio
3.06

Growth (CAGR, ttm) · 10Y

Sales
-0.95%
Net income
-9.44%
FCF
-3.69%
Shares
-3.87%

Per-share growth (CAGR, ttm) · 10Y

EPS
-5.50%
Sales/share
+3.03%
FCF/share
+0.18%
Book value/share
+10.36%
Price
-3.47%
Total return
-3.47%

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)
21.8×
Fwd P/E
12.2×
P/S (ttm)
3.0×
P/B (mrq)
1.6×
P/FCF (ttm)
12.3×
EV/EBITDA (fy)
9.0×
EV/Sales (ttm)
3.3×
FCF yield (ttm)
8.12%
Buyback yield (ttm)
0.00%
Shareholder yield (ttm)
0.00%

Vs own 10Y history

P/E
75th
P/S
30th
P/B
17th
P/FCF
46th

Bar = where today's multiple sits in BIIB's own 10-year range:near a decade-low (cheap)near a decade-high (rich).

Performance

1D
+0.78%
1W
-1.84%
1M
+1.30%
3M
+7.62%
YTD
+13.70%
1Y
+54.37%
5Y
-37.71%

Financial statements

Open full BIIB financials →

Related Healthcare

1M
TickerThemePrice1M30D $Vol
LLY
Eli Lilly and Company
Pharmaceuticals$1,196+7.05%3.2B
JNJ
Johnson & Johnson
Pharmaceuticals$263+9.30%2.1B
ABBV
AbbVie Inc.
Biopharma$259+10.36%1.9B
UNH
UnitedHealth Group Incorporated Common Stock (DE)
$421+3.66%2.6B
MRK
Merck & Co. Inc.
Pharmaceuticals$131+8.70%1.3B
TMO
Thermo Fisher Scientific Inc.
Life Sciences$568+15.45%1.1B
AMGN
Amgen Inc.
Biotech$376+7.00%969.4M
ABT
Abbott Laboratories
Medical Devices$103+13.95%1.3B

Biogen Inc. (BIIB) trades at $202.19 with a live price and an interactive chart covering 34+ years of daily price history, plus key valuation metrics. ChartRow also publishes BIIB's financial statements free — annual and quarterly income statement, balance sheet, and cash flow straight from SEC filings, with P/E and valuation history and dividend data. See full BIIB financial statements →